Abstract
Background
Phencyclidine (PCP) is a synthetic compound derived from piperidine and used as an anesthetic and hallucinogenic. Little has been recently published regarding the clinical presentation of PCP intoxication. PCP use as a recreational drug is resurging.
Objective
Our objective was to describe clinical findings in patients presenting to the emergency department (ED) under the influence of PCP.
Methods
This was a case series study conducted at a tertiary care center with an annual census of 100,000 patients/year. Emergency physicians, residents, physician assistants, and research assistants identified patients with possible PCP intoxication. Self-reported PCP use, report by bystanders or Emergency Medical Services (EMS) staff, was used in this process. A structured data collection form was completed, documenting both clinical and behavioral events observed by the treating team during the ED visit.
Results
We collected data on 219 patients; 184 were analyzed; two patients were excluded secondary to incomplete data. The mean age of patients was 32.5 years (±7 years) with 65.2 % being males. PCP use was self-reported by 60.3 % of patients. Of the 184 patients, 153 (83.1 %) received a urine drug screen (UDS); 152 (98.7 %) were positive for PCP. On arrival, 78.3 % of patients were awake and alert, and 51.6 % were oriented to self, time/date, and place. Mean physiological parameters were the following: heart rate 101.1 bpm (±24.3), RR 18.9 bpm (±3.4), BP 146.3 (±19.4)/86.3 (±14.0) mmHg, 36.9° C (±0.5), and pulse oximetry 98.2 % (±1.9). Clinical findings were the following: retrograde amnesia in 46 (25 %), horizontal nystagmus in 118 (64.1 %), vertical nystagmus in 90 (48.9 %), hypertension in 87 (47.3 %), and agitation in 71 (38.6 %). Concomitant use of at least one other substance was reported by 99 (53.8 %) patients. The mean length of stay in the ED for all subjects was 261.1 (±172.8) minutes. Final disposition for 152 (82.6 %) patients was to home. Of the 184 patients, 14 (7.6 %) required admission; 12 were referred to Crisis Response Center.
Conclusion
Patients with PCP intoxication tended to be young males. The prevalent clinical signs and symptoms were the following: retrograde amnesia, nystagmus, hypertension, and psychomotor agitation. Co-use of other substances was the norm. Most patients presenting to the ED with PCP intoxication do well and can be discharged home after a period of observation.
References
Drug Abuse Warning Network, 2011: national estimates of drug-related emergency department visits http://www.samhsa.gov/data/2k13/DAWN2k11ED/DAWN2k11ED.htm#high3.
Drug enforcement administration office of diversion control drug & chemical evaluation section on PCP Jan 2013.
Monitoring the Future: National survey results on drug use 2013 overview http://www.monitoringthefuture.org/pubs/monographs/mtf-overview2013.pdf.
Pourmand A, Armstrong P, Mazer-Amirshahi M, Shokoohi H. The evolving high: new designer drugs of abuse. Hum Exp Toxicol. 2014.
McCarron MM, Schulze BW, Thompson GA, Conder MC, Goetz WA. Acute phencyclidine intoxication: clinical patterns, complications, and treatment. Ann Emerg Med. 1981;10(6):290–7.
McCarron MM, Schulze BW, Thompson GA, Conder MC, Goetz WA. Acute phencyclidine intoxication: incidence of clinical findings in 1,000 cases. Ann Emerg Med. 1981;10(5):237–42.
Barton CH, Sterling ML, Vaziri ND. Phencyclidine intoxication: clinical experience in 27 cases confirmed by urine assay. Ann Emerg Med. 1981;10(5):243–6.
Davis BL. The PCP epidemic: a critical review. Int J Addict. 1982;17(7):1137–55.
Multigent Urine Drug Assay: phencyclidene package insert for Architect/Aeroset system developed by Abbott Laboratories, Abbott Park, Illinois, USA.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dominici, P., Kopec, K., Manur, R. et al. Phencyclidine Intoxication Case Series Study. J. Med. Toxicol. 11, 321–325 (2015). https://doi.org/10.1007/s13181-014-0453-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13181-014-0453-9